. 2017 Mar;51(1):13–19. doi: 10.4314/gmj.v51i1.3

Table 2.

Correlates for anti-HBs responses in vaccinated infants

	Reponses after completion of 3 vaccine doses (N=424)
	Seroconversion			Sero-protection (≥10 mIU/ml)			≥100 mIU/ml
Variables	Anti-HBs	No response	p value	≥10 mIU/ml	<10 mIU/ml	p value	≥100 mIU/ml	<100 mIU/ml	p value
Mean Age (Months)	13.45	15.23	*.020*	13.41	15.02	*0.020*	12.95	14.46	*.007*
[CI]	[12.86–14.04]	[13.84–16.62]		[12.80–14.02]	[13.80–16.25]		[12.15–13.75]	[13.71–15.20]
Sex/Male (%)	86.05	13.95	.353	82.79	17.21	.173	53.02	46.98	.051
[CI]	[81.42–90.68]	[9.32–18.58]		[77.74–87.84]	[12.16–22.26]		[46.35–59.69]	[40.31–53.65]
EBF/Yes (%)	83.56	16.44	.461	80.14	19.86	.968	50.00	50.00	.312
[CI]	[79.31–87.81]	[12.19–20.69]		[75.56–84.72]	[15.28–24.44]		[44.27–55.73]	[44.27–55.73]
Single Vaccine/Yes	82.84	17.16	.234	77.99	22.01	.136	43.28	56.72	*.006*
(%)	[78.33–87.35]	[12.68–21.72]		[73.03–82.95]	[12.68–21.72]		[37.35–49.21]	[50.79–62.65]
[CI]
T_{6, 10, 14}/Yes (%)	85.59	14.41	.211	81.08	18.92	.378	48.95	51.05	.636
[CI]	[81.82–89.36]	[10.64–18.18]		[76.87–85.29]	[14.71–23.13]		[43.58–54.32]	[45.68–56.42]

EBF, exclusive breast feeding; Single Vaccine, infants vaccinated with vaccine from only one pharmaceutical company; T_{6, 10, 14}, infants received vaccine doses in a timely manner at 6, 10 and 14 weeks after birth.